122 Grants (Page 4 of 5)
2000
DISCONTINUING THERAPY IN SUBJECTS W/ DISSEMINATED MAC
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S5-0687), 12/01/1999 -- 11/30/2000
 
DISCONTINUING THERAPY IN SUBJECTS W/ DISSEMINATED MAC
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-28-0687), 12/01/1999 -- 11/30/2000
 
DISCONTINUING THERAPY IN SUBJECTS W/ DISSEMINATED MAC
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S3-0687), 12/01/1999 -- 11/30/2000
 
DISCONTINUING THERAPY IN SUBJECTS W/ DISSEMINATED MAC
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S2-0687), 12/01/1999 -- 11/30/2000
 
DISCONTINUING THERAPY IN SUBJECTS W/ DISSEMINATED MAC
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S4-0687), 12/01/1999 -- 11/30/2000
 
FOUR DRUG ANTIRETROVIRAL REGIMEN ALONE OR COMB IN HIV
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S5-0719), 12/01/1999 -- 11/30/2000
 
FOUR DRUG ANTIRETROVIRAL REGIMEN ALONE OR COMB IN HIV
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S2-0719), 12/01/1999 -- 11/30/2000
 
FOUR DRUG ANTIRETROVIRAL REGIMEN ALONE OR COMB IN HIV
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S3-0719), 12/01/1999 -- 11/30/2000
 
FOUR DRUG ANTIRETROVIRAL REGIMEN ALONE OR COMB IN HIV
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S4-0719), 12/01/1999 -- 11/30/2000
 
FOUR DRUG ANTIRETROVIRAL REGIMEN ALONE OR COMB IN HIV
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-28-0719), 12/01/1976 -- 11/30/2004
 
PHASE II STUDY OF INTERMITTENT RECOMBINANT HUMAN INTERLEUKIN 2
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-28-0614), 12/01/1999 -- 11/30/2000
 
PHASE II STUDY OF INTERMITTENT RECOMBINANT HUMAN INTERLEUKIN 2
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S3-0614), 12/01/1999 -- 11/30/2000
 
PHASE II STUDY OF INTERMITTENT RECOMBINANT HUMAN INTERLEUKIN 2
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S2-0614), 12/01/1999 -- 11/30/2000
 
PHASE II STUDY OF INTERMITTENT RECOMBINANT HUMAN INTERLEUKIN 2
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S5-0614), 12/01/1999 -- 11/30/2000
 
PHASE II STUDY OF INTERMITTENT RECOMBINANT HUMAN INTERLEUKIN 2
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S4-0614), 12/01/1999 -- 11/30/2000
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S5-0597), 12/01/1999 -- 11/30/2000
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-28-0597), 12/01/1999 -- 11/30/2000
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S2-0597), 12/01/1999 -- 11/30/2000
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S4-0597), 12/01/1999 -- 11/30/2000
 
PHASE IV RANDOMIZED STUDY OF FLUCONAZOLE AS CHRONIC SUPPRESSIVE THERAPY
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S3-0597), 12/01/1999 -- 11/30/2000
 
RECOMBINANT HUMAN INTERLEUKIN 12 IN HIV INFECTION
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S5-0720), 12/01/1999 -- 11/30/2000
 
RECOMBINANT HUMAN INTERLEUKIN 12 IN HIV INFECTION
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S4-0720), 12/01/1999 -- 11/30/2000
 
RECOMBINANT HUMAN INTERLEUKIN 12 IN HIV INFECTION
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S2-0720), 12/01/1999 -- 11/30/2000
 
RECOMBINANT HUMAN INTERLEUKIN 12 IN HIV INFECTION
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 3M01RR000750-28S3-0720), 12/01/1999 -- 11/30/2000
 
RECOMBINANT HUMAN INTERLEUKIN 12 IN HIV INFECTION
Goldman, Mitchell
National Institutes of Health (NIH), National Center for Research Resources (NCRR) (ID: 2M01RR000750-28-0720), 12/01/1976 -- 11/30/2004